[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"femoroacetabular-impingement-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:femoroacetabular-impingement-syndrome":148},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,46,70,102,128],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100629263",false,"NCT07472400","Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femoroacetabular Impingement Syndrome","Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months","Inclusion Criteria:\n\n* Subjects with femoroacetabular impingement syndrome, with corresponding clinical symptoms and signs, as well as validation by imaging\n* Subjects who have already consulted a surgeon specializing in hip arthroscopic surgery and whose surgery is planned to treat femoroacetabular impingement syndrome\n* Subjects aged between 18 and 40\n\nExclusion Criteria:\n\n* History of rheumatic disease, dysplasia or pediatric disease affecting the hip (Legg-Calvé; superior femoral epiphysiolysis)\n* Subject who has already undergone surgery on the hip joint\n* Subjects with a history of injury to the muscles involved in the assessments within the last year",true,"ALL","18 Years","40 Years",{"count":20,"type":21},60,"ESTIMATED","OBSERVATIONAL","The aim of this study is to identify the factors associated with successful rehabilitation following hip arthroscopy for femoroacetabular impingement syndrome and to highlight any persistent functional deficits at different key stages of rehabilitation. This is a controlled multi-observational study. The pathological hip of patients will be compared to their second healthy hip as well as to a healthy control group.\n\nAssessments of mobility, strength, functional tests, and questionnaire submissions will take place before the intervention and 3 and 6 months after the intervention.",[25,26],"Femoroacetabular Impingement Syndrome","Healthy Participants",[28,29,30,31,32],"Femoroacetabular impingement syndrome","Physical impairments","Questionnaires","Strength","mobility","RECRUITING","2026-04-28",{"date":36,"type":37},"2026-05-05","ACTUAL",{"date":39,"type":37},"2026-03-01",{"date":41,"type":21},"2027-06-30",{"name":43,"class":44},"University of Liege","OTHER",1,{"id":47,"slug":4,"hasResults":10,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":10,"sex":16,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":4,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":66,"leadSponsor":68,"locationsCount":4},"100617752","NCT07322705","Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications?","Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications? A Multicenter Prospective Randomized Controlled Trial","Inclusion Criteria:\n\n* Aged 15 to 60 years;\n* Met the diagnostic criteria of femoroacetabular impingement syndrome (FAI) and indicated for hip arthroscopy based on patient history, symptoms, signs, physical examination, imaging (pelvic anteroposterior view, frog-leg view, CT 3D reconstruction, MRI), and diagnostic injections;\n* Able to read and sign the informed consent form.\n\nExclusion Criteria:\n\n* History of high-energy hip trauma, previous ipsilateral or contralateral hip surgery, avascular necrosis of the femoral head, slipped capital femoral epiphysis, Perthes disease, severe osteoporosis, tumors, acetabular stress fractures, or proliferative or immune hip diseases;\n* Diseases causing groin numbness, foot numbness, sexual dysfunction, urinary dysfunction, skin injuries, perineal injuries, nerve injuries, radicular pain, inner or outer thigh numbness;\n* Abnormal heart, lung, liver, kidney function, severe coagulation disorders, poorly controlled diabetes, judged by the researcher to have an infection risk;\n* Consciousness disorders, psychiatric disorders, or neuromuscular dysfunction affecting lower limb function;\n* Active infection foci (systemic or local infectious lesions);\n* Pregnancy, lactation, or planned pregnancy during the clinical study period;\n* Participation in another clinical trial within the past 3 months;\n* Patients deemed unsuitable for the clinical trial by the researcher for other reasons.","15 Years","60 Years",{"count":55,"type":21},270,"INTERVENTIONAL",[58],"NA","The goal of this clinical trial is to analyze the impact of perineal post-free traction versus traditional perineal post traction on perineal complications in hip arthroscopy. The main question it aims to answer is:\n\n• Can Perineal Post-Free Traction in Hip Arthroscopy Effectively Reduce Perineal Complications? Researchers will compare the perineal-post-free traction group with the conventional perineal-post traction group to see if the former decreases perineal complications and improves efficiency without compromising surgical outcomes.\n\nParticipants will:\n\n* Undergo either perineal-post-free or standard perineal-post traction during hip arthroscopy\n* Complete nerve-injury checks on day 1 and at discharge, and hip-function questionnaires (VAS, mHHS, IHOT-12, HOS) at 3 months\n* Allow collection of operating times, hospital stay, and direct medical costs for economic analysis",[25],"NOT_YET_RECRUITING","2025-12-23",{"date":64,"type":37},"2026-01-07",{"date":64,"type":21},{"date":67,"type":21},"2026-09-30",{"name":69,"class":44},"ChunBao Li",{"id":71,"slug":4,"hasResults":10,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":10,"sex":16,"minAge":18,"maxAge":53,"enrollmentInfo":77,"targetDuration":4,"studyType":56,"phases":79,"briefSummary":80,"conditions":81,"keywords":84,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":45},"100566346","NCT06653985","Intra-articular Corticosteroid With Hyaluronic Acid Plus Physiotherapy for Hip Pathologies (NON-OP HIP)","Intra-articular Corticosteroid With Hyaluronic Acid Plus Physiotherapy for Hip Pathologies (NON-OP HIP) - a Randomized Controlled Trial","NON-OP HIP","Inclusion Criteria:\n\n1. Patients aged 40-60 years old.\n2. Patients with mild hip arthritis (Kellgren-Lawrence grade 2 or lower) with or without a labral tear and\u002For femoroacetabular impingement and\u002For mild hip dysplasia.\n3. Patients who demonstrate more than 50% reduction in hip pain following a diagnostic injection (ultrasound guided intra-articular anaesthetic only).\n4. Able to subsidize private physiotherapy services.\n5. Able to provide informed consent.\n\nExclusion Criteria:\n\n1. Active infection\n2. Osteonecrosis of the hip, moderate to severe arthritis (Kellgren-Lawrence grade 3 or higher), or moderate-to-severe hip dysplasia\n3. Previous hip fracture, pelvic fracture, or lower limb fracture,\n4. Previous surgery to the pelvis, hip or lower limb\n5. Hypermobility disorder or connective tissue disease (e.g. Ehler's-Danlos syndrome, Marfan's syndrome etc.)\n6. Patients with chronic low back pain and\u002For sciatica\n7. Patients who received an intra-articular steroid hip injection within 3 months\n8. Patients who have previously received a hyaluronic acid injection\n9. Injuries sustained in a motor vehicle collision.\n10. Injuries sustained in the workplace and have a worker's compensation claim.\n11. Injuries resulting in a medico-legal dispute.\n12. Patients who are pregnant of planning to become pregnant\n13. Currently enrolled in a study that does not permit co-enrollment\n14. Unable to obtain informed consent\n15. Unable to comply with the study protocol\n16. Contraindication to corticosteroid or hyaluronic acid injection\n17. Prior enrollment in the study.",{"count":78,"type":21},100,[58],"Hip pathologies that cause pain and functional limitations are common in the general population. These can include femoroacetabular impingement (FAI), labral tears and mild osteoarthritis (OA) among others. While more severe and symptomatic cases may require surgical intervention, the treatment of mild-to-moderate cases is often treated without surgery to relieve pain, improve function, and delay surgical intervention.\n\nNon-operative treatments of hip pathologies consist of a multitude of options. A common non-operative intervention includes intra-articular injections, including corticosteroids and hyaluronic acid. Evidence has demonstrated that corticosteroids have fast acting effects which tend to diminish within a few months, while hyaluronic acid has a delayed time of onset and demonstrates clinical benefit for a longer period of time. Studies have evaluated combinations of corticosteroid and hyaluronic acid, hoping to take advantage of the fast-acting relief of corticosteroid and the longer lasting benefits of corticosteroid.\n\nPhysiotherapy is also a frequent non-operative intervention used to relieve pain and increase function in patients with hip pathologies. While many studies have looked at intra-articular injections and physiotherapy as independent non-operative possibilities for hip conditions, the combined effect of these two have not received much evaluation. The purpose of this study is to evaluate the effect of physiotherapy in conjunction with a combined corticosteroid and hyaluronic acid intraarticular injection on patient outcomes when compared to a corticosteroid and hyaluronic acid intraarticular injection alone.",[82,25,83],"Osteoarthritis","Labrum Injury of the Hip Joint",[85,82,86,87,88,89,90,91],"Hip","Femoroacetabular impingement","Labral tear","Hyaluronic acid","Corticosteroid","Physical Therapy","Physiotherapy","2025-09-27",{"date":94,"type":37},"2025-10-02",{"date":96,"type":37},"2024-05-01",{"date":98,"type":21},"2026-10-31",{"name":100,"class":101},"ArthroBiologix Inc.","INDUSTRY",{"id":103,"slug":4,"hasResults":10,"nctId":104,"briefTitle":105,"officialTitle":105,"acronym":4,"eligibilityCriteria":106,"healthyVolunteers":10,"sex":16,"minAge":107,"maxAge":18,"enrollmentInfo":108,"targetDuration":4,"studyType":56,"phases":110,"briefSummary":112,"conditions":113,"keywords":114,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":119,"lastUpdatePostDateStruct":120,"startDateStruct":122,"completionDateStruct":124,"leadSponsor":126,"locationsCount":4},"100601296","NCT07108647","In-Season Prevalence and Management of Hip and Groin Injuries in Competitive Athletes","Inclusion Criteria:\n\n* currently identifies as a \"competitive athlete\" based on the LTAD\n* aged 14-40\n* be free from any significant lower extremity injury (hip, groin, knee, ankle foot) in the past 6 months that resulted in \\>1 months of time loss or current inability to fully participate in sport at the time of baseline testing\n\nIf participants meet the above criteria, can be screened:\n\n\\- completed bilateral hip screen, including imaging, and identified as having FAI syndrome with no degenerative joint changes (if meet the remaining criteria,\n\nExclusion Criteria:\n\n* Are currently experiencing or recovering from a lower extremity injury that resulted in \\>1 month time lost within the past 6 months\n* are pregnant or may become pregnant during the study (due to radiographic imaging exposure)\n* \\* participants will be excluded from eligibility of RCT if they have evidence of moderate to severe osteoarthritis on imaging (Tönnis grade 2-3)","14 Years",{"count":109,"type":21},30,[111],"PHASE1","This study is focused on helping athletes with a common hip condition called femoroacetabular impingement (FAI) syndrome. FAI syndrome occurs when abnormal bone shapes around the hip joint cause friction during movement, leading to pain, reduced performance, and, over time, more serious injury. While this issue is well-studied in male professional athletes, little is known about how it affects female and collegiate athletes, or how to prevent it from worsening.\n\nIn this study, athletes diagnosed with FAI syndrome will participate in a 12-week in-season exercise program designed to reduce pain, improve hip strength and movement, and help prevent further injury-all while continuing their regular sports training.\n\nParticipants will be randomly assigned to either:\n\n* An exercise group (receiving the intervention), or\n* A time-and-attention control group (regular check-ins and education).\n\nAt the end of the study, the control group will have the option to access the exercise program.\n\nThe study will track changes in pain, physical performance, injury recurrence, and athlete satisfaction with the program. This research aims to improve how we manage hip injuries in athletes and help keep them active during the competitive season.",[25],[115,116,117,118],"athletes","competitive","adolescent","young adult","2025-08-05",{"date":121,"type":37},"2025-08-07",{"date":123,"type":21},"2025-08-01",{"date":125,"type":21},"2026-09-01",{"name":127,"class":44},"University of Calgary",{"id":129,"slug":4,"hasResults":10,"nctId":130,"briefTitle":131,"officialTitle":132,"acronym":4,"eligibilityCriteria":133,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":134,"targetDuration":4,"studyType":56,"phases":135,"briefSummary":136,"conditions":137,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":45},"100581086","NCT06845735","Absorbable vs Non-Absorbable Sutures for Hip Capsular Closure","Prospective Randomized Control Trial Comparing Absorbable Sutures to Non-Absorbable Sutures for Capsular Closures in Hip Arthroscopies","Inclusion Criteria:\n\n* Subjects 18 years of age and older.\n* Subject requiring surgical hip arthroscopic intervention for their hip pathology\n\nExclusion Criteria:\n\n* Subjects less than 18 years of age.\n* Subjects with any other medical problem precluding anesthesia or surgery.\n* Unable to provide informed consent.",{"count":78,"type":21},[58],"The study is to prospectively compare absorbable sutures with non-absorbable sutures used for capsular repair during hip arthroscopic procedures. Major outcomes will be measured using three questionnaires ((1) International Hip Outcome Tool-12 (iHOT-12), (2) modified Harris hip score, (3) hip outcome score) in addition to the standard of care set of 9 questionnaires. The other major outcome will be any radiographic heterotrophic ossification at the 6-month follow-up time point.",[83,138,25],"Hip Arthroscopy","2025-05-01",{"date":141,"type":37},"2025-05-04",{"date":143,"type":37},"2024-03-22",{"date":145,"type":21},"2028-01-01",{"name":147,"class":44},"University of Missouri-Columbia",""]